Nektar Therapeutics Common Stock (NKTR)

Typically moves ±5.90% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED

Nektar Therapeutics Common Stock (NKTR) has a 20-report earnings history dating back to Aug 05, 2021. Its average absolute post-earnings move is ±5.90%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +10.73% (Aug 04, 2022) and its largest decline was -19.24% (Nov 04, 2021). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings reactions

How NKTR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.90%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☽ POST	-1.99%	open_in_new
Mar 12, 2026	☽ POST	+4.33%	open_in_new
Nov 06, 2025	☽ POST	+1.94%	open_in_new
Aug 07, 2025	☽ POST	+5.27%	open_in_new
May 08, 2025	☽ POST	-3.93%	open_in_new
Mar 12, 2025	☽ POST	+1.97%	open_in_new
Nov 07, 2024	☽ POST	+2.19%	open_in_new
Aug 08, 2024	☽ POST	-7.47%	open_in_new
May 09, 2024	☽ POST	+10%	open_in_new
Mar 04, 2024	☽ POST	-1.22%	open_in_new
Nov 07, 2023	☽ POST	-7.65%	open_in_new
Aug 08, 2023	☽ POST	-11.32%	open_in_new
May 09, 2023	☽ POST	-3.14%	open_in_new
Feb 28, 2023	☽ POST	+9.42%	open_in_new
Nov 03, 2022	☽ POST	+6.18%	open_in_new
Aug 04, 2022	☽ POST	+10.73%	open_in_new
May 05, 2022	☽ POST	-2.14%	open_in_new
Feb 28, 2022	☽ POST	+7.33%	open_in_new
Nov 04, 2021	☽ POST	-19.24%	open_in_new
Aug 05, 2021	☽ POST	-0.63%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.90%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 17 →

Funds holding

$140864943

Total value held

Buying

15 added · 2 reduced

Blackrock, Inc.

$49836168 +7.29%

Morgan Stanley

$47442895 +16.41%

State Street Corp

$17608108 +25.08%

Goldman Sachs Group Inc

$9133477 -14.11%

Northern Trust Corp

$5655126 +40.16%

SEC Filing Types

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260702	open_in_new SEC.gov
144	20260630	open_in_new SEC.gov
4	20260618	open_in_new SEC.gov
144	20260617	open_in_new SEC.gov
4	20260617	open_in_new SEC.gov
144	20260616	open_in_new SEC.gov
144	20260615	open_in_new SEC.gov
8-K	20260605	open_in_new SEC.gov
3	20260526	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov

Frequently asked about NKTR earnings

When does Nektar Therapeutics Common Stock report earnings next? expand_more

Nektar Therapeutics Common Stock (NKTR)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NKTR stock move after earnings? expand_more

Over 20 reports, NKTR has moved an average of ±5.90% the session after earnings, closing higher 50.0% of the time.

What was NKTR's biggest post-earnings move? expand_more

NKTR's largest post-earnings gain on record was +10.73% on Aug 04, 2022, and its largest decline was -19.24% on Nov 04, 2021.

Where can I find Nektar Therapeutics Common Stock's SEC filings? expand_more

All of Nektar Therapeutics Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Nektar Therapeutics Common Stock (NKTR)

Earnings reactions

Earnings Impact

Historical Earnings Statistics

Institutional ownership

SEC Filing Types

Recent SEC Filings

Frequently asked about NKTR earnings

Sector peers

Reporting around the same time